Methicillin-resistant Staphylococcus aureus infection does not adversely affect clinical outcome of lower extremity amputations

Annals of Vascular Surgery

Volumn 17, Issue 1, 2003, Pages 80-85

  Cerveira, Joaquim J ^a,b   Lal, Brajesh K ^a   Padberg Jr , Frank T ^a   Pappas, Peter J ^a   Hobson II, Robert W ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; METICILLIN; VANCOMYCIN;

ADULT; AGED; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONFERENCE PAPER; CORRELATION ANALYSIS; DEBRIDEMENT; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LEG AMPUTATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; NONHUMAN; OUTCOMES RESEARCH; PATIENT MONITORING; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SURGICAL MORTALITY; TREATMENT INDICATION;

EID: 0037284435     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-001-0341-z     Document Type: Conference Paper

References (20)

1. Pechere JC. Current and future management of infections due to methicillin-resistant staphylococci infections: the role of quinupristin/dalfopristin. J Antimicrob Chemother(Topic A) 1999;44:11-18.
2. Gottlieb GS, Fowler Jr VG, Kong LK, et al. Staphylococcus aureus bacteremia in the surgical patient: a prospective analysis of 73 postoperative patients who developed Staphylococcus aureus bacteremia at a tertiary care facility. J Am Coll Surg 2000;190:50-57.
3. National Nosocomial Infection Surveillance Report. Data summary from October 1986 through April 1998. Atlanta: Hospital Infection Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1998.
4. Jones RN, Ballow CH, Biedenbach DJ, et al. Antimicrobial activity of quinupristin-dalfopristin tested against 28,000 recent clinical isolates from 200 medical centers in the United States and Canada. Diagn Microbiol Infect Dis 1998;31:437-457.
5. Li J, Wilke R, Pinto L, et al. Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin; a randomized, multicenter trial. Pharmacotherapy 2001;21:263-274.
6. Carbon C. Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci. J Antimicrob Chemother 1999;44:31-36.
7. Naylor AR, Hayes PD, Darke S. A prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA. Eur J Vasc Endovasc Surg 2001;21:289-294.
8. Menon KV, Whiteley MS, Burden P, Galland RB. Surgical patients with methicillin resistant Staphylococcus aureus infection: an analysis of outcome using P-POSSUM. JR Coll Surg Edinb 1999;44:161-163.
9. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria Grown Aerobically, 3rd Edition: Approved Standard M7-A3. Villanova, PA: NCCLS, 1993.
10. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517-538.
11. Witte W. Antibiotic resistance in gram-positive bacteria: epidemiological aspects. J Antimicrob Chemother 1999;44:1-9.
12. Spencer RC. Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study. Eur J Clin Microbiol Infect Dis 1996;15:281-285.
13. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA 1995;274:639-644.
14. Criado E, De Stefano AA, Keagy BA, et al. The course of severe foot infection in patients with diabetes. Surg Gyneiol Obstet 1992;175:135-140.
15. Ibelings MM, Bruining HA. Methicillin-resistant Staphylococcus aureus: acquisition and risk of death in patients in the intensive care unit. Eur J Surg 1998;164:411-418.
16. Barie PS. Antibiotic-resistant gram-positive cocci: implications for surgical practice. World J Surg 1998;22:118-126.
17. Grimble SAJ, Magee TR, Galland RB. Methicillin-resistant Staphylococcus aureus in patients undergoing major amputation. Eur J Vasc Endovasc Surg 2001;22:215-218.
18. Nasim A, Thompson MM, Naylor AR, et al. The impact of MRSA on vascular surgery. Eur J Vasc Endovasc Surg 2001;22:211-214.
19. Bodily KC, Burgess EM. Contralateral limb and patient survival after leg amputations. Am J Surg 1983;146:280-282.
20. Ayliffe GA, Buckles A, Casewell MW, et al. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. J Hosp Infect 1998;39:253-290.